Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Arthritis, Rheumatoid × Leflunomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Smoldering Multiple Myeloma 2 Pancreatic Neoplasms 2 Melanoma 2 Glioma 2 Central Nervous System Neoplasms 2 Brain Neoplasms 2 Triple Negative Breast Neoplasms 1 Sarcoma 1 Prostatic Neoplasms 1 PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer 1 Neuroendocrine Tumors 1 Neoplasms 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia 1 Lung Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Colorectal Neoplasms 1 Breast Neoplasms 1 Breast Diseases 1 Astrocytoma 1 Arthritis, Rheumatoid 1 Acute Graft Versus Host Disease 1

Interventions

Methotrexate 9 Adalimumab 9 Etanercept 8 tocilizumab 4 Abatacept 4 tofacitinib 3 olokizumab 3 golimumab 3 Rituximab 3 Tumor Necrosis Factor Inhibitors 2 RC-18 2 Nivolumab 2 Infliximab 2 Antirheumatic Agents 2 veltuzumab 1 upadacitinib 1 secukinumab 1 sarilumab 1 mavrilimumab 1 entecavir 1 baricitinib 1 andecaliximab 1 Vitamin D 1 Sulfasalazine 1 Specimen Handling 1 Saline Solution 1 Radioimmunodetection 1 Pharmaceutical Preparations 1 Lysine Acetyltransferase 5 1 Leflunomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03449758 2022-04-28

SariPRO

Sanofi

Phase 4 Completed

84 enrolled 36 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡